Cargando…
Atorvastatin population pharmacokinetics in a real‐life setting: Influence of genetic polymorphisms and association with clinical response
The purpose of this study was to investigate the potential clinical relevance of estimating the apparent clearance (CL/F) of atorvastatin through population pharmacokinetic (PopPK) modeling with samples collected in a real‐life setting in a cohort of ambulatory patients at risk of cardiovascular dis...
Autores principales: | Stillemans, Gabriel, Paquot, Adrien, Muccioli, Giulio G., Hoste, Emilia, Panin, Nadtha, Åsberg, Anders, Balligand, Jean‐Luc, Haufroid, Vincent, Elens, Laure |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932751/ https://www.ncbi.nlm.nih.gov/pubmed/34761521 http://dx.doi.org/10.1111/cts.13185 |
Ejemplares similares
-
Genetic Polymorphisms in SLCO2B1 and ABCC1 Conjointly Modulate Atorvastatin Intracellular Accumulation in HEK293 Recombinant Cell Lines
por: Hoste, Emilia, et al.
Publicado: (2023) -
Effect of four ABCB1 genetic polymorphisms on the accumulation of darunavir in HEK293 recombinant cell lines
por: Stillemans, Gabriel, et al.
Publicado: (2021) -
Impact of ABCB1 1236C > T-2677G > T-3435C > T polymorphisms on the anti-proliferative activity of imatinib, nilotinib, dasatinib and ponatinib
por: Dessilly, Géraldine, et al.
Publicado: (2016) -
Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell lines
por: Sennesael, Anne-Laure, et al.
Publicado: (2018) -
Optimal sampling strategies for darunavir and external validation of the underlying population pharmacokinetic model
por: Stillemans, Gabriel, et al.
Publicado: (2020)